Literature DB >> 22393093

Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare.

Mary Beth Landrum1, Nancy L Keating, Elizabeth B Lamont, Samuel R Bozeman, Steven H Krasnow, Lawrence Shulman, Jennifer R Brown, Craig C Earle, Michael Rabin, Barbara J McNeil.   

Abstract

PURPOSE: The Veterans Health Administration (VHA) provides high-quality preventive chronic care and cancer care, but few studies have documented improved patient outcomes that result from this high-quality care. We compared the survival rates of older patients with cancer in the VHA and fee-for-service (FFS) Medicare and examined whether differences in the stage at diagnosis, receipt of guideline-recommended therapies, and unmeasured characteristics explain survival differences. PATIENTS AND METHODS: We used propensity-score methods to compare all-cause and cancer-specific survival rates for men older than age 65 years who were diagnosed or received their first course of treatment for colorectal, lung, lymphoma, or multiple myeloma in VHA hospitals from 2001 to 2004 to similar FFS-Medicare enrollees diagnosed in Surveillance, Epidemiology, and End Results (SEER) areas in the same time frame. We examined the role of unmeasured factors by using sensitivity analyses.
RESULTS: VHA patients versus similar FFS SEER-Medicare patients had higher survival rates of colon cancer (adjusted hazard ratio [HR], 0.87; 95% CI, 0.82 to 0.93) and non-small-cell lung cancer (NSCLC; HR, 0.91; 95% CI, 0.88 to 0.95) and similar survival rates of rectal cancer (HR, 1.05; 95% CI, 0.95 to 1.16), small-cell lung cancer (HR, 0.99; 95% CI, 0.93 to 1.05), diffuse large-B-cell lymphoma (HR, 1.02; 95% CI, 0.89 to 1.18), and multiple myeloma (HR, 0.92; 95% CI, 0.83 to 1.03). The diagnosis of VHA patients at earlier stages explained much of the survival advantages for colon cancer and NSCLC. Sensitivity analyses suggested that additional adjustment for the severity of comorbid disease or performance status could have substantial effects on estimated differences.
CONCLUSION: The survival rate for older men with cancer in the VHA was better than or equivalent to the survival rate for similar FFS-Medicare beneficiaries. The VHA provision of high-quality care, particularly preventive care, can result in improved patient outcomes.

Entities:  

Mesh:

Year:  2012        PMID: 22393093      PMCID: PMC3341151          DOI: 10.1200/JCO.2011.35.6758

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  37 in total

1.  Marginal structural models as a tool for standardization.

Authors:  Tosiya Sato; Yutaka Matsuyama
Journal:  Epidemiology       Date:  2003-11       Impact factor: 4.822

2.  Hospital use and survival among Veterans Affairs beneficiaries.

Authors:  Carol M Ashton; Julianne Souchek; Nancy J Petersen; Terri J Menke; Tracie C Collins; Kenneth W Kizer; Steven M Wright; Nelda P Wray
Journal:  N Engl J Med       Date:  2003-10-23       Impact factor: 91.245

3.  Effect of the transformation of the Veterans Affairs Health Care System on the quality of care.

Authors:  Ashish K Jha; Jonathan B Perlin; Kenneth W Kizer; R Adams Dudley
Journal:  N Engl J Med       Date:  2003-05-29       Impact factor: 91.245

4.  The annual report to the nation on the status of cancer, 1973-1997, with a special section on colorectal cancer.

Authors:  L A Ries; P A Wingo; D S Miller; H L Howe; H K Weir; H M Rosenberg; S W Vernon; K Cronin; B K Edwards
Journal:  Cancer       Date:  2000-05-15       Impact factor: 6.860

5.  Outcome of myocardial infarction in Veterans Health Administration patients as compared with medicare patients.

Authors:  L A Petersen; S L Normand; J Daley; B J McNeil
Journal:  N Engl J Med       Date:  2000-12-28       Impact factor: 91.245

6.  Development of a comorbidity index using physician claims data.

Authors:  C N Klabunde; A L Potosky; J M Legler; J L Warren
Journal:  J Clin Epidemiol       Date:  2000-12       Impact factor: 6.437

7.  Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use.

Authors:  Z Agha; R P Lofgren; J V VanRuiswyk; P M Layde
Journal:  Arch Intern Med       Date:  2000-11-27

8.  Practice guideline for the role of combination chemotherapy in the initial management of limited-stage small-cell lung cancer.

Authors:  Scott A Laurie; Diane Logan; Barbara R Markman; Jean A Mackay; William K Evans
Journal:  Lung Cancer       Date:  2004-02       Impact factor: 5.705

9.  Regionalization and the underuse of angiography in the Veterans Affairs Health Care System as compared with a fee-for-service system.

Authors:  Laura A Petersen; Sharon-Lise T Normand; Lucian L Leape; Barbara J McNeil
Journal:  N Engl J Med       Date:  2003-05-29       Impact factor: 91.245

10.  Is patient travel distance associated with survival on phase II clinical trials in oncology?

Authors:  Elizabeth B Lamont; Davinder Hayreh; Kate E Pickett; James J Dignam; Marcy A List; Kerstin M Stenson; Daniel J Haraf; Bruce E Brockstein; Sarah A Sellergren; Everett E Vokes
Journal:  J Natl Cancer Inst       Date:  2003-09-17       Impact factor: 13.506

View more
  35 in total

1.  Contemporary Use of Partial Nephrectomy: Are Older Patients With Impaired Kidney Function Being Left Behind?

Authors:  John T Leppert; Harsha R Mittakanti; I-Chun Thomas; Remy W Lamberts; Geoffrey A Sonn; Benjamin I Chung; Eila C Skinner; Todd H Wagner; Glenn M Chertow; James D Brooks
Journal:  Urology       Date:  2016-09-12       Impact factor: 2.649

2.  Association of Early Patient-Physician Care Planning Discussions and End-of-Life Care Intensity in Advanced Cancer.

Authors:  Sangeeta C Ahluwalia; Diana M Tisnado; Anne M Walling; Sydney M Dy; Steven M Asch; Susan L Ettner; Benjamin Kim; Philip Pantoja; Hannah C Schreibeis-Baum; Karl A Lorenz
Journal:  J Palliat Med       Date:  2015-07-17       Impact factor: 2.947

3.  Palliative Care Specialist Consultation Is Associated With Supportive Care Quality in Advanced Cancer.

Authors:  Anne M Walling; Diana Tisnado; Susan L Ettner; Steven M Asch; Sydney M Dy; Philip Pantoja; Martin Lee; Sangeeta C Ahluwalia; Hannah Schreibeis-Baum; Jennifer L Malin; Karl A Lorenz
Journal:  J Pain Symptom Manage       Date:  2016-07-09       Impact factor: 3.612

Review 4.  Comparing VA and Non-VA Quality of Care: A Systematic Review.

Authors:  Claire O'Hanlon; Christina Huang; Elizabeth Sloss; Rebecca Anhang Price; Peter Hussey; Carrie Farmer; Courtney Gidengil
Journal:  J Gen Intern Med       Date:  2016-07-15       Impact factor: 5.128

5.  Military and veteran health behavior research and practice: challenges and opportunities.

Authors:  Jeffrey P Haibach; Michael Ann Haibach; Katherine S Hall; Robin M Masheb; Melissa A Little; Robyn L Shepardson; Anne C Dobmeyer; Jennifer S Funderburk; Christopher L Hunter; Margaret Dundon; Leslie R M Hausmann; Stephen K Trynosky; David E Goodrich; Amy M Kilbourne; Sara J Knight; Gerald W Talcott; Michael G Goldstein
Journal:  J Behav Med       Date:  2016-09-27

6.  Incident CKD after Radical or Partial Nephrectomy.

Authors:  John T Leppert; Remy W Lamberts; I-Chun Thomas; Benjamin I Chung; Geoffrey A Sonn; Eila C Skinner; Todd H Wagner; Glenn M Chertow; James D Brooks
Journal:  J Am Soc Nephrol       Date:  2017-10-10       Impact factor: 10.121

7.  Tumor boards and the quality of cancer care.

Authors:  Nancy L Keating; Mary Beth Landrum; Elizabeth B Lamont; Samuel R Bozeman; Lawrence N Shulman; Barbara J McNeil
Journal:  J Natl Cancer Inst       Date:  2012-12-28       Impact factor: 13.506

8.  Cancer Among Women Treated in the Veterans Affairs Healthcare System.

Authors:  Leah L Zullig; Karen M Goldstein; Kellie J Sims; Christina D Williams; Michael Chang; Dawn Provenzale; Michael J Kelley
Journal:  J Womens Health (Larchmt)       Date:  2018-06-19       Impact factor: 2.681

9.  Geographic variation in cancer-related imaging: Veterans Affairs health care system versus Medicare.

Authors:  J Michael McWilliams; Jesse B Dalton; Mary Beth Landrum; Austin B Frakt; Steven D Pizer; Nancy L Keating
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

10.  Time trends in glioblastoma multiforme survival: the role of temozolomide.

Authors:  Robert Dubrow; Amy S Darefsky; Daniel I Jacobs; Lesley S Park; Michal G Rose; Maxwell S H Laurans; Joseph T King
Journal:  Neuro Oncol       Date:  2013-09-17       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.